Compare WAY & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAY | IRTC |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.8B |
| IPO Year | 2023 | 2016 |
| Metric | WAY | IRTC |
|---|---|---|
| Price | $25.06 | $150.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 13 |
| Target Price | $37.60 | ★ $210.85 |
| AVG Volume (30 Days) | ★ 3.1M | 620.4K |
| Earning Date | 05-20-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 569.23 | 61.71 |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $1,099,278,000.00 | $747,138,000.00 |
| Revenue This Year | $17.99 | $18.26 |
| Revenue Next Year | $10.41 | $15.44 |
| P/E Ratio | $41.10 | ★ N/A |
| Revenue Growth | 16.50 | ★ 26.24 |
| 52 Week Low | $21.13 | $92.52 |
| 52 Week High | $45.00 | $210.01 |
| Indicator | WAY | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 51.31 |
| Support Level | $21.13 | $142.51 |
| Resistance Level | $26.29 | $157.28 |
| Average True Range (ATR) | 1.42 | 7.99 |
| MACD | 0.39 | 1.57 |
| Stochastic Oscillator | 72.14 | 72.02 |
Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for solutions extends throughout the United States and includes Puerto Rico and other USA Territories.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.